Methods and formulations for use in treating oophorectomized...

Details Methods and formulations for use in treating oophorectomized... Methods and formulations for use in treating oophorectomized...

A - Human Necessities

61

K

A61K 31/56 (2006.01) A61K 9/16 (2006.01) A61K 31/37 (2006.01) A61K 31/565 (2006.01) A61K 31/57 (2006.01)

Patent

CA 2162260

Compositions and methods which are effective to prevent symptoms of loss of ovarian function (e.g., in oophorectomized women) over a period of time are described, consisting essentially of an effective amount of an estrogenic composition and an effective amount of an androgenic composition. The levels of estrogens and androgens employed are sufficient to reduce bone mineral density loss and minimize other side effects observed after oophorectomy, and at such low doses as to minimize any adverse impact on the patient's long-term prognosis or (in the case of testosterone) result in additional side effects.

Affiliated with

Also associated with

Rating

Methods and formulations for use in treating oophorectomized... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and formulations for use in treating oophorectomized..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and formulations for use in treating oophorectomized... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1433524